John McKune - 01 Dec 2023 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
Interim CFO
Signature
/s/ John McKune
Issuer symbol
LUNG
Transactions as of
01 Dec 2023
Transactions value $
-$9,739
Form type
4
Filing time
05 Dec 2023, 17:44:37
Previous filing
19 Oct 2023
Next filing
07 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale -$1.39K -135 -0.33% $10.33 41.2K 01 Dec 2023 Direct F1
transaction LUNG Common Stock Sale -$2.3K -222 -0.54% $10.34 41K 01 Dec 2023 Direct F2
transaction LUNG Common Stock Sale -$6.05K -585 -1.43% $10.34 40.4K 01 Dec 2023 Direct F3
transaction LUNG Common Stock Award $0 +7.23K +17.9% $0.00 47.6K 01 Dec 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
F2 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
F3 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
F4 Represents grant of the RSUs payable solely in common stock of the Issuer that will become fully vested on December 1, 2024.